The attorney general of Texas is demanding documents from the manufacturers of puberty-blocking drugs as part of an investigation probing whether they have engaged in practices that violate state law.
U.S. regulators on Tuesday authorized another COVID-19 booster for people age 50 and older, a step to offer extra protection for the most vulnerable in case the coronavirus rebounds.
Truckers protesting the Biden administration’s reluctance to give up its COVID-19 pandemic-induced emergency powers are now headed to California to fight against proposed vaccine-related legislation.
Swedish researchers showed the mRNA from the Pfizer COVID-19 vaccine can be reverse-transcribed into DNA in human liver cells in vitro, but more research is needed to determine if this transcribed vaccine-derived DNA can integrate into human genomic DNA.
Letting politicians dictate patient care, which prevents physicians from practicing medicine and saving patients’ lives, is a core problem, say Drs. Robert Malone and Peter McCullough.
Pfizer CEO Albert Bourla on Sunday said the vaccine maker plans to submit data on a fourth dose of its COVID-19 vaccine to the U.S. Food and Drug Administration because protection after three doses is “not that good against infections” and “doesn’t last very long” when faced with a variant like Omicron.